← Back to Clinical Trials
Recruiting NCT07430150

NCT07430150 Long Lasting Effect of Hyperbaric Oxygen Therapy on Cognitive Function in Traumatic Brain Injury Patients

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07430150
Status Recruiting
Phase
Sponsor Assaf-Harofeh Medical Center
Condition TBI (Traumatic Brain Injury)
Study Type OBSERVATIONAL
Enrollment 100 participants
Start Date 2021-12-28
Primary Completion 2030-01

Trial Parameters

Condition TBI (Traumatic Brain Injury)
Sponsor Assaf-Harofeh Medical Center
Study Type OBSERVATIONAL
Phase N/A
Enrollment 100
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2021-12-28
Completion 2030-01

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

To evaluate the cognitive functions of patients who suffered brain injury due to traumatic head injury and were previously treated in a hyperbaric chamber between one and four years after the end of treatment.

Eligibility Criteria

Inclusion Criteria: 1. Diagnosed with traumatic brain injury 2. Age 18 years or older at treatment 3. Completed a 60 session hyperbaric treatment course at the Sagol Center for Hyperbaric Medicine and Research, Shamir Medical Center (Assaf Harofeh), and performed a neurocognitive evaluation by the computerized test Neurotrax. 4. Willing and able to sign an informed consent. - Exclusion Criteria: 1. An inability to perform a neurocognitive computerized test. 2. Any head trauma, neurodegenerative diseases or CVA after hyperbaric treatment completion. 3. Diagnosis of a psychiatric disorder including: major depression, schizophrenia, bipolar disorder 4. Active malignancy 5. Chronic use of medications that may compromise cognitive function

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology